Dean F Bajorin Selected Research

Dean F Bajorin Research Topics

Disease

86	Neoplasms (Cancer) 04/2024 - 01/2002
58	Carcinoma (Carcinomatosis) 01/2024 - 09/2006
39	Urinary Bladder Neoplasms (Bladder Cancer) 05/2024 - 03/2002
16	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 09/2023 - 11/2002
11	Neoplasm Metastasis (Metastasis) 12/2020 - 01/2007
7	Teratoma (Teratoid Tumor) 10/2019 - 12/2003
7	Testicular Neoplasms (Testicular Cancer) 04/2010 - 12/2003
5	Non-Muscle Invasive Bladder Neoplasms 05/2024 - 04/2016
4	Nonseminomatous germ cell tumor 08/2018 - 12/2007
4	Transitional Cell Carcinoma 03/2011 - 12/2003
3	Carcinoma in Situ 05/2024 - 04/2017
3	Fatigue 10/2022 - 01/2018
3	Fibrosis (Cirrhosis) 01/2019 - 01/2002
3	Carcinogenesis 12/2017 - 12/2010
2	Hearing Loss (Hearing Impairment) 09/2023 - 06/2011
2	Small Cell Carcinoma 10/2022 - 01/2021
2	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2008
2	Pathologic Complete Response 01/2021 - 04/2010
2	Disease Progression 01/2021 - 01/2002
2	Margins of Excision 10/2020 - 12/2019
2	Embryonal Carcinoma 01/2017 - 08/2005
2	Hypoxia (Hypoxemia) 08/2011 - 03/2011
2	Breast Neoplasms (Breast Cancer) 11/2009 - 01/2008
2	Leukemia 10/2009 - 12/2003
2	Seminoma 01/2002 - 01/2002
1	Rare Diseases (Rare Disease) 01/2024
1	Ototoxicity 09/2023
1	Diarrhea 01/2023
1	Human Influenza (Influenza) 01/2022
1	Urachal adenocarcinoma 01/2022
1	Pneumonia (Pneumonitis) 01/2021

Drug/Important Bio-Agent (IBA)

32	Cisplatin (Platino)FDA LinkGeneric 04/2024 - 01/2002
20	PlatinumIBA 01/2023 - 01/2002
13	Gemcitabine FDA Link 04/2024 - 02/2007
12	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2002
11	Immune Checkpoint InhibitorsIBA 11/2022 - 10/2018
9	NivolumabIBA 02/2023 - 10/2018
8	pembrolizumabIBA 05/2024 - 01/2017
8	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 09/2014
7	Carboplatin (JM8)FDA LinkGeneric 09/2023 - 02/2007
7	B7-H1 AntigenIBA 01/2023 - 01/2017
7	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 01/2002
7	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 02/2007
6	atezolizumabIBA 01/2022 - 01/2017
5	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 01/2002
5	AntibodiesIBA 01/2019 - 12/2003
5	Ifosfamide FDA LinkGeneric 01/2016 - 02/2007
4	ChromatinIBA 12/2022 - 02/2015
4	Hemoglobins (Hemoglobin)IBA 01/2018 - 04/2013
4	CreatinineIBA 01/2018 - 02/2007
4	Everolimus FDA Link 04/2017 - 10/2012
4	TOR Serine-Threonine KinasesIBA 08/2013 - 03/2011
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2008
3	durvalumabIBA 01/2023 - 12/2020
3	RNA (Ribonucleic Acid)IBA 04/2018 - 06/2006
3	AlbuminsIBA 01/2018 - 04/2013
3	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2009 - 02/2007
3	VaccinesIBA 11/2008 - 12/2003
3	AntigensIBA 03/2007 - 12/2003
2	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 05/2021 - 12/2020
2	tremelimumabIBA 01/2021 - 12/2020
2	IpilimumabIBA 01/2021 - 12/2020
2	Phosphotransferases (Kinase)IBA 10/2020 - 02/2015
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2020 - 09/2010
2	ElementsIBA 10/2019 - 04/2018
2	Bevacizumab (Avastin)FDA Link 03/2016 - 02/2013
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2016 - 10/2015
2	Pemetrexed (MTA)FDA Link 05/2015 - 06/2007
2	Sunitinib (Sutent)FDA Link 08/2011 - 03/2010
2	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 04/2010 - 04/2010
1	erdafitinibIBA 11/2023
1	Amylases FDA Link 01/2023
1	Lipase (Acid Lipase)FDA Link 01/2023
1	Genetic Markers (Genetic Marker)IBA 01/2023
1	palladium-bacteriopheophorbideIBA 01/2023
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2023
1	Photosensitizing Agents (Photosensitizers)IBA 01/2023
1	olaparibIBA 01/2023
1	padeliporfinIBA 01/2023
1	Circulating Tumor DNAIBA 12/2022
1	Transcription Factors (Transcription Factor)IBA 11/2022
1	Blocking AntibodiesIBA 01/2021

Therapy/Procedure

61	Drug Therapy (Chemotherapy) 04/2024 - 01/2002
41	Therapeutics 04/2024 - 12/2003
24	Cystectomy 05/2024 - 03/2002
18	Neoadjuvant Therapy 04/2024 - 02/2007
18	Lymph Node Excision (Lymph Node Dissection) 01/2024 - 03/2002
15	Immunotherapy 11/2022 - 04/2016
7	Salvage Therapy 01/2024 - 04/2010
6	Adjuvant Chemotherapy 10/2022 - 08/2005
5	Combination Drug Therapy (Combination Chemotherapy) 12/2019 - 06/2011
3	Nephroureterectomy 01/2024 - 01/2016
3	Aftercare (After-Treatment) 01/2018 - 02/2015
2	Induction Chemotherapy 02/2015 - 02/2008
2	Radiotherapy 01/2014 - 01/2008
2	Orchiectomy (Orchidectomy) 11/2011 - 04/2010
1	Hearing Aids (Hearing Aid) 09/2023
1	Intravenous Infusions 01/2023
1	Photochemotherapy (Photodynamic Therapy) 01/2023
1	Chemoradiotherapy 10/2022